# Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment

> **NCT04637360** · NA · COMPLETED · sponsor: **Min-Sheng General Hospital** · enrollment: 40 (actual)

## Conditions studied

- Hyperparathyroidism; Secondary, Renal

## Interventions

- **DRUG:** Cinacalcet Tablets
- **DRUG:** calcitriol

## Key facts

- **NCT ID:** NCT04637360
- **Lead sponsor:** Min-Sheng General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2020-06-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-11-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04637360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04637360, "Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04637360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*